James Mchugh - Jan 6, 2022 Form 4 Insider Report for EXELON CORP (EXC)

Signature
Elizabeth M. Hensen, Attorney-in-Fact for James McHugh
Stock symbol
EXC
Transactions as of
Jan 6, 2022
Transactions value $
-$215,120
Form type
4
Date filed
1/10/2022, 04:17 PM
Previous filing
Dec 16, 2021
Next filing
Feb 1, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EXC Common Stock Options Exercise +12.9K +50.29% 38.5K Jan 6, 2022 Direct F1
transaction EXC Common Stock Tax liability -$215K -3.79K -9.86% $56.73 34.7K Jan 6, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EXC 2019 Restricted Stock Units Options Exercise -4.31K -100% 0 Jan 6, 2022 Common Stock 4.31K $0.00 Direct F2, F3
transaction EXC 2020 Restricted Stock Units Options Exercise -4.18K -50.01% 4.18K Jan 6, 2022 Common Stock 4.18K $0.00 Direct F2, F4
transaction EXC 2021 Restricted Stock Units Options Exercise -4.39K -33.34% 8.77K Jan 6, 2022 Common Stock 4.39K $0.00 Direct F2, F5
holding EXC Deferred Compensation Phantom Shares 2.21K Jan 6, 2022 Common Stock 2.21K $0.00 Direct F6
holding EXC Restricted Stock Unit Award 4/5/2021 20.5K Jan 6, 2022 Common Stock 20.5K $0.00 Direct F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Common shares acquired through conversion of previously awarded and vested restricted stock units (RSUs) under the Exelon Long Term Incentive Plan.
F2 Vesting of previously granted restricted stock unit (RSU) awarded under Exelon Long Term Incentive Plan. Awards granted annually to vest in 1/3 increments at the January or February meetings of the Compensation Committee with each RSU representing the right to receive one share of Exelon common stock upon vesting. RSUs accrue quarterly dividend equivalents in the form of additional RSUs representing common stock dividends as approved by the Board, which vest on the same schedule as the underlying RSU award.
F3 The RSU award accrued 30 additional shares during 2021 from the date that Mr. McHugh became a reporting person through automatic dividend reinvestment.
F4 The RSU award accrued 59 additional shares during 2021 from the date that Mr. McHugh became a reporting person through automatic dividend reinvestment.
F5 The RSU award accrued 93 additional shares during 2021 from the date that Mr. McHugh became a reporting person through automatic dividend reinvestment.
F6 Phantom share equivalents held in the Exelon stock fund within the Exelon Deferred Compensation Plan, which is multi-fund, non-qualified deferred compensation plan. The share equivalents within the fund will be settled in cash upon the reporting person's separation from the company for any reason. The balance includes 40 additional share equivalents acquired during 2021 from the date that Mr. McHugh became a reporting person through automatic dividend reinvestment.
F7 Restricted stock unit award granted pursuant to the Exelon LTI plan. The award accrues quarterly dividend equivalents in the form of additional RSUs representing common stock dividends as approved by the Board. All shares will cliff vest on April 5, 2025. Balance includes 144 additional shares accrued during 2021 from the date that Mr. McHugh became a reporting person through automatic dividend reinvestment.